Stoke Therapeutics, Inc.

NASDAQ:STOK

13.27 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 150.016193.551178.581191.442189.977192.06190.339113.556113.39667.75484.111144.895149.038169.07267.514287.308191.461201.93211.288222.471233.049242.6898.651105.399-1.797
Short Term Investments 89.18488.50609.95224.74139.38763.334116.039138.259207.876209.10574.91587.11882.15600000000003.594
Cash and Short Term Investments 239.2282.057178.581201.394214.718231.447253.673229.595251.655275.63293.216219.81236.156251.226267.514287.308191.461201.93211.288222.471233.049242.6898.651105.3991.797
Net Receivables 0.6910.3050.0110.0640.0960.1360.4920.5880.3950.350.2650.1320.0450.1310.0060.0060.0020.0090.1440.2810.3760.260.1960.1960
Inventory 000010.93610.9510.19110.932000-0.1320000000000000
Other Current Assets 13.72114.63214.28113.8814.2693.6995.882.95512.55113.17912.299.4088.7328.8767.7756.6163.9933.6054.3423.2813.2551.5052.4290.5480
Total Current Assets 253.612296.994192.873215.339230.019246.232270.236244.07264.601289.159305.771229.218244.933260.233275.295293.93195.456205.544215.774226.033236.68244.445101.276106.1431.797
Non-Current Assets:
Property, Plant & Equipment, Net 9.26110.26911.33812.4349.30110.11810.99111.42812.45611.6999.5989.0788.2694.1423.5553.794.2744.4654.8622.5121.9421.7221.3961.1920
Goodwill 0000000000000000000000000
Intangible Assets 0000000000000000000000000
Goodwill and Intangible Assets 0000000000000000000000000
Long Term Investments 29.9520.4940.5690.5690.5690.5690.5690.5690.5690.5690.5690.5690.5690.0750.0580000000000
Tax Assets 0000000000000000000000000
Other Non-Current Assets 0.494-00.4020000000000000.2050.2050.2050.2050.2050.2050.2050.2620.204-1.797
Total Non-Current Assets 39.70710.76312.30913.0039.8710.68711.5611.99713.02512.26810.1679.6478.8384.2173.6133.9954.4794.675.0672.7172.1471.9271.6581.396-1.797
Total Assets 293.319307.757205.182228.342239.889256.919281.796256.067277.626301.427315.938238.865253.771264.45278.908297.925199.935210.214220.841228.75238.827246.372102.934107.5390
Liabilities & Equity:
Current Liabilities:
Account Payables 2.4853.9452.1021.6953.0761.5564.2990.7661.9113.6023.3282.3850.6550.9631.4961.4951.0950.9041.7790.7511.7891.2381.1261.0710
Short Term Debt 2.2982.2772.2132.0622.4982.452.4042.3592.3132.081.5351.5071.4250.59201.0661.1191.0921.065000000
Tax Payables 0000000000000000000000000
Deferred Revenue 31.61226.05120.91815.3098.7358.05913.45114.8812.83810.6348.46912.7079.4766.0560-1.0664.2663.3142.557000000
Other Current Liabilities 13.4712.22310.35711.75310.8929.77211.37313.38911.73311.3339.5730.540.3280.5864.6148.8640.2550.4950.0543.353.1273.582.2171.3960
Total Current Liabilities 49.86544.49635.5930.81925.20121.83731.52731.39428.79527.64922.90517.13911.8848.1976.1111.4256.7355.8055.4554.1014.9164.8183.3432.4670
Non-Current Liabilities:
Long Term Debt 004.1254.7730.8191.4622.0942.7173.3183.9113.1353.5323.9150.6830.020.080.2960.5840.868000000
Deferred Revenue Non-Current 8.29116.94625.04233.07440.7343.25834.14436.85641.07845.2149.54500000000000000
Deferred Tax Liabilities Non-Current 000-4.773-0.819-1.462-2.094-2.717-3.318-3.911-3.13500000000000000
Other Non-Current Liabilities 3.053.6060.0834.8840.9591.6292.3032.9683.614.2470.3760.4170.4590.5010.3130.3420.3690.4250.1760.2210.2280.0180.010.0040
Total Non-Current Liabilities 11.34120.55229.2537.95841.68944.88736.44739.82444.68849.45753.0563.9494.3741.1840.3330.4220.6651.0091.0440.2210.2280.0180.010.0040
Total Liabilities 61.20665.04864.8468.77766.8966.72467.97471.21873.48377.10675.96121.08816.2589.3816.44311.8477.46.8146.4994.3225.1444.8363.3532.4710
Equity:
Preferred Stock 00000000000000000000000.0020.0020.005
Common Stock 0.0050.0050.0050.0050.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0030.0030.0030.0030.0030.0030.00100
Retained Earnings -480.348-453.918-428.223-401.849-374.891-350.349-319.695-297.15-271.495-245.384-220.732-196.083-171.635-149.038-127.071-110.278-95.717-82.033-69.074-58.035-47.875-39.271-31.452-25.710
Accumulated Other Comprehensive Income/Loss 0.166-0.0150-0.024-0.147-0.379-0.598-1.175-1.703-1.276-0.684-0.168-0.022-0.042-0-0-000-0.815000-0.379-1.297
Other Total Stockholders Equity 712.29696.637568.56561.433548.033540.919534.111483.17477.337470.977461.389414.024409.166404.145399.532396.352288.249285.43283.413283.275281.555280.804131.03131.1550
Total Shareholders Equity 232.113242.709140.342159.565172.999190.195213.822184.849204.143224.321239.977217.777237.513255.069272.465286.078192.535203.4214.342224.428233.683241.53699.581105.068-1.292
Total Equity 232.113242.709140.342159.565172.999190.195213.822184.849204.143224.321239.977217.777237.513255.069272.465286.078192.535203.4214.342224.428233.683241.53699.581105.068-1.292
Total Liabilities & Shareholders Equity 293.319307.757205.182228.342239.889256.919281.796256.067277.626301.427315.938238.865253.771264.45278.908297.925199.935210.214220.841228.75238.827246.372102.934107.539-1.292